| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffd5528fd07384d7b07ab484ed5b143 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 |
| filingDate |
2017-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53cd30b07c6259898d1dd491d53c0e92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7914c13c1ff57102076ad9a4934d1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f719b22ca14c660b1e221d9973c3057e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a5e8bea05a19950ddcc3d133c16928b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a31c9dd3f619df982e9d18f28994b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c60222e55af6d186982e874b0f3c487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f8f9a9e660b0b972cd8aad740463af6 |
| publicationDate |
2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3442582-A1 |
| titleOfInvention |
Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative |
| abstract |
An anti-myeloid-derived suppressor cells agent ("anti-MDSCs agent") and a bacteriochlorophyll derivative (hereinafter "Bchl-D) for use in combination therapy for cancer, wherein the anti-MDSC agent and the Bchl-D are administered sequentially and the administration of the Bchl-D is followed by photodynamic therapy (PDT) or vascular targeted PDT (VTP). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10024339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10107240-B2 |
| priorityDate |
2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |